MORGAN STANLEY - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$8,634
-27.5%
6,693
-25.8%
0.00%
Q2 2023$11,905
+86.7%
9,0190.0%0.00%
Q1 2023$6,376
-69.0%
9,019
-67.1%
0.00%
Q4 2022$20,587
-84.0%
27,449
-81.6%
0.00%
Q3 2022$129,000
+9.3%
149,091
+41.8%
0.00%
Q2 2022$118,000
-39.5%
105,137
-39.5%
0.00%
Q1 2022$195,000
-41.6%
173,824
-16.7%
0.00%
Q4 2021$334,000
+554.9%
208,668
+887.0%
0.00%
Q3 2021$51,000
-71.2%
21,142
-62.0%
0.00%
Q2 2021$177,000
+18.8%
55,591
+26.1%
0.00%
Q1 2021$149,000
+893.3%
44,071
+974.9%
0.00%
Q4 2020$15,000
+7.1%
4,100
-24.1%
0.00%
Q3 2020$14,000
+100.0%
5,400
+131.5%
0.00%
Q2 2020$7,000
+600.0%
2,333
+366.6%
0.00%
Q1 2020$1,000
-87.5%
500
-77.4%
0.00%
Q4 2019$8,000
-89.9%
2,216
-91.6%
0.00%
Q3 2019$79,000
+132.4%
26,412
+98.0%
0.00%
Q2 2019$34,00013,3420.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,048,757$6,904,0002.75%
Asymmetry Capital Management, L.P. 1,063,264$3,583,0001.85%
Endurant Capital Management LP 1,339,835$4,515,0001.18%
Altium Capital Management LP 1,250,000$4,213,0001.17%
Affinity Asset Advisors, LLC 900,000$3,033,0001.03%
DAFNA Capital Management LLC 1,249,648$4,211,0001.00%
Boxer Capital, LLC 6,226,673$20,984,0000.71%
Delphi Management Partners VIII, L.L.C. 256,734$865,0000.60%
Rubric Capital Management LP 2,914,861$9,823,0000.57%
Orbimed Advisors 17,264,763$58,183,0000.54%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders